30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Patheon BV (PTHN)

Track

Stock chart
Ticker: PTHN Exchange: NYQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
LEVY PAUL S
1 purchase — total 149,000 USD
Buy 30 Sep 2016
Value US$1,123,626.34 | Price 459.29 | Shares 78,660
Buy 29 Sep 2016
Value US$4,241,787.02 | Price 321.56 | Shares 53,096
Buy 28 Sep 2016
Value US$148,050.00 | Price 29.61 | Shares 5,000
Buy 27 Sep 2016
Value US$148,250.00 | Price 29.65 | Shares 5,000
Buy 26 Sep 2016
Value US$148,250.00 | Price 29.65 | Shares 5,000
Buy 12 Sep 2016
Value US$1,036,370.00 | Price 28.01 | Shares 37,000
Buy 26 Jul 2016
Value US$799,495.52 | Price 19.85 | Shares 40,287
Buy 26 Jul 2016
Value US$15,388,666.34 | Price 19.85 | Shares 775,443
Sale 26 Jul 2016
Value US$94,500,004.72 | Price 19.85 | Shares 4,761,905
Buy 26 Jul 2016
Value US$198,450.00 | Price 19.85 | Shares 10,000
Buy 26 Jul 2016
Value US$968,436.00 | Price 19.85 | Shares 48,800
Buy 21 Jul 2016
Value US$700,000.00 | Price 25.00 | Shares 28,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-10-03 2016-09-30 B Purchase LEVY PAUL S Non-Executive Director
78,660 +17.9%
459.29
US$1,123,626 		78,660 +17.9% 459.29 US$1,123,626
2016-10-03 2016-09-29 B Purchase LEVY PAUL S Non-Executive Director
53,096 +39.0%
321.56
US$4,241,787 		53,096 +39.0% 321.56 US$4,241,787
2016-09-28 2016-09-28 B Purchase LEVY PAUL S Non-Executive Director
48,255 -45.1%
36.92
US$1,811,851 		48,255 -45.1% 36.92 US$1,811,851
2016-09-28 2016-09-27 B Purchase LEVY PAUL S Non-Executive Director
5,000 +11.9%
29.65
US$148,250 		5,000 +11.9% 29.65 US$148,250
2016-09-28 2016-09-26 B Purchase LEVY PAUL S Non-Executive Director
5,000 +13.5%
29.65
US$148,250 		5,000 +13.5% 29.65 US$148,250
2016-09-14 2016-09-12 B Purchase LEVY PAUL S Non-Executive Director
37,000 +inf%
28.01
US$1,036,370 		37,000 +inf% 28.01 US$1,036,370
2016-07-28 2016-07-26 B Purchase JLL Associates G.P. V (Patheon), Ltd. Large shareholder
40,287 +inf%
19.85
US$799,496 		40,287 +inf% 19.85 US$799,496
2016-07-28 2016-07-26 S Sale Koninklijke DSM N.V. Large shareholder
4,761,905 -8.9%
19.85
US$94,500,005 		4,761,905 -8.9% 19.85 US$94,500,005
2016-07-28 2016-07-26 B Purchase McMullen Jeffrey P Non-Executive Director
10,000 +84.0%
19.85
US$198,450 		10,000 +84.0% 19.85 US$198,450
2016-07-28 2016-07-26 B Purchase Daley Pamela Non-Executive Director
48,800 +409.9%
19.85
US$968,436 		48,800 +409.9% 19.85 US$968,436
2016-07-28 2016-07-26 B Purchase JLL Associates G.P. V (Patheon), Ltd. Large shareholder
775,443 +3.3%
19.85
US$15,388,666 		775,443 +3.3% 19.85 US$15,388,666
2016-07-25 2016-07-21 B Purchase Eykerman Philip Non-Executive Director
28,000 +inf%
25.00
US$700,000 		28,000 +inf% 25.00 US$700,000
Explore more

More insider trading research around Patheon BV

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America